Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy-Reference-Cited by-同舟云学术

Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy

Published:2010-02 Issue:2 Volume:125 Page:e51-e54
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Zuern Christine S.,Geisler Tobias,Lutilsky Natalia,Winter Stefan,Schwab Matthias,Gawaz Meinrad

Publisher

Elsevier BV

Subject

Hematology

Reference26 articles.

1. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study;Gilard;J Am Coll Cardiol,2008

2. Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin;Gilard;J Thromb Haemost,2006

3. CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation;Geisler;Pharmacogenomics,2008

4. Review article: cytochrome P450 and the metabolism of proton pump inhibitors–emphasis on rabeprazole;Ishizaki;Aliment Pharmacol Ther,1999

5. Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently;Farid;Clin Pharmacol Ther,2007

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis;Frontiers in Pharmacology;2023-01-10

2. Esomeprazole inhibits endoplasmic reticulum stress and ameliorates myocardial ischemia-reperfusion injury;Biochemical and Biophysical Research Communications;2022-10

3. P2Y12 Antagonists in Cardiovascular Disease—Finding the Best Balance Between Preventing Ischemic Events and Causing Bleeding;Frontiers in Cardiovascular Medicine;2022-05-12

4. Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial;British Journal of Haematology;2021-10-05

5. The opioid-P2Y12 inhibitor interaction: Potential strategies to mitigate the interaction and consideration of alternative analgesic agents in myocardial infarction;Pharmacology & Therapeutics;2021-01